Inaktiver Wert

Cornerstone Therapeutics, Inc. Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Inc. Stockholders Approve Merger	28.02.14
Cornerstone Therapeutics Inc. Stockholders Approve Merger	03.02.14
Cornerstone Therapeutics Adjourns Special Meeting of Stockholders	01.02.14
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa	20.11.13
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call	31.10.13

Sektor

	% 1. Jan.	Kap.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.37%	43.54 Mrd.
OTSUKA HOLDINGS CO., LTD.	+19.44%	21.78 Mrd.
SANDOZ GROUP AG	+17.85%	15.38 Mrd.
CIPLA LIMITED	+25.55%	15.12 Mrd.
ZYDUS LIFESCIENCES LIMITED	+60.99%	13.36 Mrd.
THE MEDICINES COMPANY	-0.05%	6.79 Mrd.
ONO PHARMACEUTICAL CO., LTD.	-15.02%	6.38 Mrd.
STADA ARZNEIMITTEL	-8.87%	5.73 Mrd.
ASPEN PHARMACARE HOLDINGS LIMITED	+8.17%	5.32 Mrd.